{"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"5"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"4"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"8"},{"groupId":"BG009","value":"8"},{"groupId":"BG010","value":"4"},{"groupId":"BG011","value":"4"},{"groupId":"BG012","value":"10"},{"groupId":"BG013","value":"1"},{"groupId":"BG014","value":"69"}],"units":"Participants"}],"groups":[{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG000","title":"Part 1 / Treatment Group A: 15 MG QD INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG001","title":"Part 1 / Treatment Group A: 22.5 MG QD INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG002","title":"Part 1 / Treatment Group A: 15 MG BID INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG003","title":"Part 1 / Treatment Group A: 30 MG QD INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG004","title":"Part 1 / Treatment Group A: 22.5 MG BID INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. 5/2=5 days on/2 days off.\n\nTreatment Group A included any advanced solid tumor or lymphoma.","id":"BG005","title":"Part 1 / Treatment Group A: 22.5 MG BID 5/2 INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. 4/3=4 days on/3 days off. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG006","title":"Part 1 / Treatment Group A: 22.5 MG BID 4/3 INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. 7/7=7 days on/7 days off. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG007","title":"Part 1 / Treatment Group A: 22.5 MG BID 7/7 INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG008","title":"Part 1 / Treatment Group A: 20 MG BID INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. 5/2=5 days on/2 days off. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG009","title":"Part 1 / Treatment Group A: 25 MG BID 5/2 INCB054329"},{"description":"Part 1 / treatment group A (TGA): Initial cohort dose of INCB054329 monotherapy at the protocol-specified starting dose in the TGA. 7/7=7 days on/7 days off. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG010","title":"Part 1 / Treatment Group A: 25 MG BID 7/7 INCB054329"},{"description":"Part 1 / treatment group B (TGB): Initial cohort dose of INCB054329 monotherapy at the protocol-specified cohort escalation treatment group B (TGB), based on protocol-specific criteria. Treatment Group B included acute leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasms, or myelofibrosis.","id":"BG011","title":"Part 1 / Treatment Group B: 20 MG BID INCB054329"},{"description":"Part 2 / treatment group A (TGA): dose titration was to determine the feasibility of intraparticipant dose titration using Protocol-defined criteria. Treatment Group A included any advanced solid tumor or lymphoma.","id":"BG012","title":"Part 2 / Treatment Group A: 20 MG BID INCB054329"},{"description":"Part 2 / treatment group C (TGC): dose titration was to determine the feasibility of intraparticipant dose titration using Protocol-defined criteria. Treatment Group C included multiple myeloma.","id":"BG013","title":"Part 2 / Treatment Group C: 20 mg BID INCB054329"},{"description":"Total of all reporting groups","id":"BG014","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"4.03","value":"62.3"},{"groupId":"BG001","spread":"13.39","value":"54.8"},{"groupId":"BG002","spread":"8.50","value":"57.7"},{"groupId":"BG003","spread":"7.86","value":"63.6"},{"groupId":"BG004","spread":"5.77","value":"68.7"},{"groupId":"BG005","spread":"21.73","value":"49.3"},{"groupId":"BG006","spread":"12.40","value":"61.5"},{"groupId":"BG007","spread":"16.20","value":"68.3"},{"groupId":"BG008","spread":"17.55","value":"58.4"},{"groupId":"BG009","spread":"14.84","value":"60.9"},{"groupId":"BG010","spread":"16.58","value":"50.3"},{"groupId":"BG011","spread":"8.77","value":"71.8"},{"groupId":"BG012","spread":"14.20","value":"59.3"},{"groupId":"BG013","value":"66.0"},{"groupId":"BG014","spread":"13.59","value":"60.03"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"2"},{"groupId":"BG007","value":"1"},{"groupId":"BG008","value":"3"},{"groupId":"BG009","value":"4"},{"groupId":"BG010","value":"1"},{"groupId":"BG011","value":"2"},{"groupId":"BG012","value":"7"},{"groupId":"BG013","value":"1"},{"groupId":"BG014","value":"36"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"2"},{"groupId":"BG007","value":"2"},{"groupId":"BG008","value":"5"},{"groupId":"BG009","value":"4"},{"groupId":"BG010","value":"3"},{"groupId":"BG011","value":"2"},{"groupId":"BG012","value":"3"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"33"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"1"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"4"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"4"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"7"},{"groupId":"BG009","value":"8"},{"groupId":"BG010","value":"4"},{"groupId":"BG011","value":"4"},{"groupId":"BG012","value":"9"},{"groupId":"BG013","value":"1"},{"groupId":"BG014","value":"64"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"00"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"1"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"1"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"4"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"5"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"4"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"7"},{"groupId":"BG009","value":"8"},{"groupId":"BG010","value":"4"},{"groupId":"BG011","value":"3"},{"groupId":"BG012","value":"10"},{"groupId":"BG013","value":"1"},{"groupId":"BG014","value":"65"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.02","value":"167.3"},{"groupId":"BG001","spread":"11.47","value":"172.7"},{"groupId":"BG002","spread":"9.80","value":"169.1"},{"groupId":"BG003","spread":"10.48","value":"164.6"},{"groupId":"BG004","spread":"12.12","value":"172.0"},{"groupId":"BG005","spread":"16.52","value":"164.8"},{"groupId":"BG006","spread":"16.64","value":"170.8"},{"groupId":"BG007","spread":"14.65","value":"174.2"},{"groupId":"BG008","spread":"7.05","value":"173.6"},{"groupId":"BG009","spread":"12.60","value":"170.5"},{"groupId":"BG010","spread":"7.41","value":"179.8"},{"groupId":"BG011","spread":"13.29","value":"167.0"},{"groupId":"BG012","spread":"10.40","value":"160.8"},{"groupId":"BG013","value":"159.0"},{"groupId":"BG014","spread":"11.47","value":"168"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Height","unitOfMeasure":"cm"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.19","value":"70.0"},{"groupId":"BG001","spread":"11.14","value":"66.2"},{"groupId":"BG002","spread":"18.32","value":"71.7"},{"groupId":"BG003","spread":"18.30","value":"79.7"},{"groupId":"BG004","spread":"18.55","value":"77.6"},{"groupId":"BG005","spread":"19.12","value":"70.2"},{"groupId":"BG006","spread":"24.39","value":"72.3"},{"groupId":"BG007","spread":"24.18","value":"82.3"},{"groupId":"BG008","spread":"18.24","value":"87.3"},{"groupId":"BG009","spread":"23.65","value":"77.6"},{"groupId":"BG010","spread":"36.32","value":"88.4"},{"groupId":"BG011","spread":"5.85","value":"84.8"},{"groupId":"BG012","spread":"19.90","value":"66.3"},{"groupId":"BG013","value":"58.0"},{"groupId":"BG014","spread":"19.82","value":"75.69"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Weight","unitOfMeasure":"kg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"4.34","value":"25.2"},{"groupId":"BG001","spread":"3.68","value":"22.3"},{"groupId":"BG002","spread":"5.00","value":"24.8"},{"groupId":"BG003","spread":"6.83","value":"29.5"},{"groupId":"BG004","spread":"4.62","value":"26.1"},{"groupId":"BG005","spread":"3.51","value":"25.5"},{"groupId":"BG006","spread":"5.10","value":"24.3"},{"groupId":"BG007","spread":"3.12","value":"26.6"},{"groupId":"BG008","spread":"4.85","value":"28.8"},{"groupId":"BG009","spread":"7.73","value":"26.7"},{"groupId":"BG010","spread":"10.69","value":"27.2"},{"groupId":"BG011","spread":"3.27","value":"30.6"},{"groupId":"BG012","spread":"6.46","value":"25.5"},{"groupId":"BG013","value":"22.9"},{"groupId":"BG014","spread":"5.75","value":"26.36"}]}]}],"description":"BMI is a measure of body fat based on height and weight that applies to adult men and women.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Body mass index (BMI)","unitOfMeasure":"kg/m^2"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"5"},{"groupId":"BG009","value":"1"},{"groupId":"BG010","value":"2"},{"groupId":"BG011","value":"1"},{"groupId":"BG012","value":"3"},{"groupId":"BG013","value":"1"},{"groupId":"BG014","value":"22"}]}],"title":"ECOG - 0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"3"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"3"},{"groupId":"BG009","value":"7"},{"groupId":"BG010","value":"2"},{"groupId":"BG011","value":"3"},{"groupId":"BG012","value":"7"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"47"}]}],"title":"ECOG - 1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"}]}],"title":"ECOG - >=2"}],"description":"ECOG performance status measured on 6 point scale to assess participant's performance status. 0=Fully active, able to carry on all pre-disease activities without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=Ambulatory (greater than \\[\\>\\]50% of waking hours), capable of all self care, unable to carry out any work activities","paramType":"COUNT_OF_PARTICIPANTS","title":"Eastern Cooperative Oncology Group (ECOG)","unitOfMeasure":"Participants"}],"populationDescription":"The safety population included all enrolled participants who received at least 1 dose of INCB054329."}